Dr Lisa Elliott is a Health Outcomes Analyst at Health Technology Analysts (HTanalysts) and a member of the Health Services Assessment Collaboration (HSAC). Dr Elliott has experience in the preparation of submissions to the Medical Services Advisory Committee (MSAC) and Pharmaceutical Benefits Advisory Committee (PBAC).
Dr Elliott completed a PhD at the University of New South Wales, studying protective immune responses in Hepatitis C Virus infection. During that time she presented her research at meetings of the Australian Centre for Hepatitis Virology, Australasian Society for HIV Medicine, Australian Society for Immunology and the International Symposium on Viral Hepatitis and Liver Disease.
After completing postgraduate studies she worked at as a clinical research associate at a contract research organisation.
Dr Elliott is a member of the Australian Association for Regulatory and Clinical Scientists
Dr Elliott’s current research interests include systematic reviews and meta-analysis of bodies of evidence, and the development of appropriate data collection strategies to inform economic evaluations.